tm logo
EXPLORE44 Logo
FORMALIZED

on 02 Jun 2023

Last Applicant/ Owned by

Avidity Biosciences, Inc.

10578 Science DriveSuite 125San Diego, CA 92121

US

Serial Number

2261728 filed on 02th Jun 2023

Correspondent Address

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

EXPLORE44 Logo

Vienna Information


1 . 3 . 1

Sun rising or settingSoleil levant ou couchant

1 . 3 . 6

Sun with landscapesSoleil avec paysages

1 . 3 . 11

Sun with manufactured articles or industrial productsSoleil avec objets manufacturés ou industriels

1 . 3 . 13

Sun with inscriptionsSoleil avec inscriptions

6 . 3 . 1

Lacustrine or maritime scenesPaysages lacustres ou marins

6 . 3 . 4

Open sea, stretches of water without shoresHaute mer, étendues d'eau sans rivage

18 . 3 . 2

Sailing boats, sailboardsBateaux à voiles, planches à voile

18 . 3 . 9

Other sailing boatsAutres bateaux à voiles

18 . 3 . 21

Sails, portholes, oars -- Note: Includes also any other parts of boats not classified in another category, division or section.Voiles, hublots, rames -- Note: Comprend également toute autre partie de bateau non classée dans une autre catégorie, division ou section.

18 . 3 . 23

Fanciful or stylized boatsBateaux de fantaisie ou stylisés

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

Trademark usage description

oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based t Read More

Classification Information


Class [005]
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders


Classification kind code

12

Class [042]
Conducting clinical trials in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; medical and scientific research, namely, conducting clinical trials for oligonucleotide-based therapeutics; conducting clinical trials; providing medical and scientific research information in the field of clinical trials; pharmaceutical research and development; research and development in the medical biotechnology field


Classification kind code

12

Class [044]
Medical and veterinary, beauty, agricultural and forestry


Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details


Serial Number

2261728

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 15th Jun 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 02th Jun 2023
Filed
Submitted for opposition 1
on 02th Jun 2023
Created
Submitted for opposition 31
on 02th Jun 2023
Formalized